See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Oct. 7, 2003

Lung Cancer Colorectal Cancer Peritoneal Cancer

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Lung Cancer

A research study of an investigational medication for the treatment of non-small-cell lung cancer (NSCLC). Volunteers at least 18 years old with histologically documented recurrent or progressive NSCLC, which is either EGFR-positive or EGFR-negative by IHC (may be based on archival samples) and is metastatic may be eligible. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat34.html.

-----

Colorectal Cancer

A research study to compare the effects of a combination of medications for the treatment of colorectal cancer. Volunteers at least 18 years old with documented colorectal cancer that is EGFR-positive and metastatic may be eligible. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat426.html.

-----

Peritoneal Cancer

A research study of an investigational medication for the treatment of ovarian, peritoneal or fallopian tube cancer. Volunteers at least 18 years old who have histologically documented ovarian, peritoneal or fallopian tube cancer, Stage III or IV following initial surgery, which is EGFR-positive by IHC (may be based on archival samples) and is metastatic may be eligible. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat553.html.

-----

Copyright 2003 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.